|
Diagnosis and Pharmacotherapy Interventions for Eating Disorders Presenter: Dina Fradkin, DNP, CNP, PMHNP-BC
Summary: The prevalence of eating disorders in females is about 8%, with 2% occurring in males as well (Galmiche et al., 2019). Eating disorders can be exceptionally difficult to diagnose due to a variety of factors, including but not limited to crossover between diagnoses. As such, many patients with anorexia nervosa end up with symptoms evolving to bulimia nervosa and vice versa, and there is significant crossover between patients with bulimia nervosa and binge eating disorder (Castellini et al., 2011). Eating disorders can also be obscured or confused with smptoms of medical illness (Devlin et al., 2011). Moreover, clinicians may be unfamiliar with atypical presentations within categories of eating disorders. For example, anorexia nervosa may be missed in an individual whose BMI is within the normal or greater than normal categories, for which a diagnosis of atypical anorexia nervosa can be provided (American Psychiatric Association, 2022). Lastly, treatment for eating disorders is primarily psychotherapeutic, and therefore, clinicians may be unaware of the pharmacology options that may be an important adjunct to treatment (Yager, 2022). Addressing both diagnostic challenges as well as treatment options is critical to expand practicing clinicians’ reach. Contact Hours: This activity has been submitted to Georgia Nurses Association for approval to award one contact hour. Georgia Nurses Association is accredited as an approver of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.
Criteria for Successful Completion Conflict of Interest Cost:
To receive ISPN member pricing, please login to the members only section of the website. Steps: First, register through our website here. You will then receive an email with links to the webinar.
Click Here to Register for the Webinar! |